SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Aug-13 6:00 PM View: | Protalix BioTherapeutics, I... (PLX) | 15-Aug-13 | Market Sale | 2,330 | $5.07 | $11,813.10 | (< 1%) 4.92M to 4.92M | 90% |
16-Aug-13 6:00 PM View: | Protalix BioTherapeutics, I... (PLX) | 14-Aug-13 | Market Sale | 110,000 | $5.05 | $555,750.00 | (2%) 5.03M to 4.92M | 90% |
14-Mar-13 7:00 PM View: | Protalix BioTherapeutics, I... (PLX) | 12-Mar-13 | Market Sale | 10,000 | $5.70 | $57,000.00 | (< 1%) 5.04M to 5.03M | 91% |
12-Mar-13 6:30 PM View: | Protalix BioTherapeutics, I... (PLX) | 11-Mar-13 | Market Sale | 18,300 | $5.72 | $104,737.00 | (< 1%) 5.06M to 5.04M | 91% |
12-Mar-13 6:30 PM View: | Protalix BioTherapeutics, I... (PLX) | 08-Mar-13 | Market Sale | 16,898 | $5.86 | $99,068.10 | (< 1%) 5.07M to 5.06M | 91% |
08-Mar-13 5:04 PM View: | Protalix BioTherapeutics, I... (PLX) | 07-Mar-13 | Market Sale | 8,435 | $5.72 | $48,232.60 | (< 1%) 5.08M to 5.07M | 91% |
08-Mar-13 5:04 PM View: | Protalix BioTherapeutics, I... (PLX) | 06-Mar-13 | Market Sale | 4,700 | $5.69 | $26,737.00 | (< 1%) 5.09M to 5.08M | 91% |